These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25864833)

  • 41. Drugs, industry, and academia.
    Fitzgerald GA
    Science; 2008 Jun; 320(5883):1563. PubMed ID: 18566251
    [No Abstract]   [Full Text] [Related]  

  • 42. Cardiovascular medicine: opportunities for enhanced university-industry collaboration. November 1983, Newport Beach, California.
    Circulation; 1985 Aug; 72(2 Pt 2):I1-56. PubMed ID: 4006151
    [No Abstract]   [Full Text] [Related]  

  • 43. Nanomedicine: industry-wise research.
    Eaton M
    Nat Mater; 2007 Apr; 6(4):251-3. PubMed ID: 17401412
    [No Abstract]   [Full Text] [Related]  

  • 44. Academia-industry dialogue: a step toward mutual understanding.
    Becker RE
    Circulation; 1985 Aug; 72(2 Pt 2):I53-6. PubMed ID: 4006161
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic monoclonal antibodies in the French community: let's get organized].
    Watiez D; Watier H
    Med Sci (Paris); 2009 Dec; 25(12):1189-92. PubMed ID: 20035704
    [No Abstract]   [Full Text] [Related]  

  • 46. A university administrator's view of academia--industry collaboration.
    Mullins CB
    Circulation; 1985 Aug; 72(2 Pt 2):I8-12. PubMed ID: 4006162
    [No Abstract]   [Full Text] [Related]  

  • 47. [Collaborative projects with academia for regulatory science studies on biomarkers].
    Saito Y; Nakamura R; Maekawa K
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):19-21. PubMed ID: 25707199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Public-private partnerships in translational medicine: concepts and practical examples.
    Luijten PR; van Dongen GA; Moonen CT; Storm G; Crommelin DJ
    J Control Release; 2012 Jul; 161(2):416-21. PubMed ID: 22465390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical issues for effective collaboration between academia and industry in the field of regenerative medicine in Japan.
    Tsubouchi M; Morishita R; Tabata Y; Matsui S; Kawakami K
    Regen Med; 2008 Jul; 3(4):497-504. PubMed ID: 18588472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nurturing clinician investigators is the best way to promote innovative drug development from academia].
    Fukuhara S; Sakushima K; Nishimura M
    Brain Nerve; 2012 Mar; 64(3):225-8. PubMed ID: 22402715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The patent craze and academia.
    Lancet; 1993 Dec; 342(8885):1435-7. PubMed ID: 7902475
    [No Abstract]   [Full Text] [Related]  

  • 52. Alzheimer's disease drug development: translational neuroscience strategies.
    Cummings JL; Banks SJ; Gary RK; Kinney JW; Lombardo JM; Walsh RR; Zhong K
    CNS Spectr; 2013 Jun; 18(3):128-38. PubMed ID: 23472637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pitching doctors.
    Wilkes MS; Shuchman M
    N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
    [No Abstract]   [Full Text] [Related]  

  • 54. [CNS drug research and development based on the human genetics and human biology].
    Hizue M
    Nihon Yakurigaku Zasshi; 2017; 149(4):154-159. PubMed ID: 28381658
    [No Abstract]   [Full Text] [Related]  

  • 55. IT infrastructure components to support clinical care and translational research projects in a comprehensive cancer center.
    Prokosch HU; Ries M; Beyer A; Schwenk M; Seggewies C; Köpcke F; Mate S; Martin M; Bärthlein B; Beckmann MW; Stürzl M; Croner R; Wullich B; Ganslandt T; Bürkle T
    Stud Health Technol Inform; 2011; 169():892-6. PubMed ID: 21893875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
    Litten RZ; Ryan M; Falk D; Fertig J
    Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Translational research in Health topics: A road for pragmatic and interdisciplinary research].
    Bernales M; Cabieses B; Obach A; Maturana A
    Rev Med Chil; 2015 Jan; 143(1):128-9. PubMed ID: 25860282
    [No Abstract]   [Full Text] [Related]  

  • 58. Industry-university co-operation. Experiences, possibilities and problems as seen from a Swedish perspective.
    Agurell S
    Pharm Weekbl Sci; 1985 Apr; 7(2):42-5. PubMed ID: 4000895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The full translational spectrum of prevention science.
    Fishbein DH
    Transl Behav Med; 2016 Mar; 6(1):1-4. PubMed ID: 27012248
    [No Abstract]   [Full Text] [Related]  

  • 60. The value of networks in driving phase I trials: the Peter MacCallum Cancer Centre experience.
    Desai J; Guo C; Tran B
    Chin Clin Oncol; 2019 Jun; 8(3):23. PubMed ID: 31311277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.